Loading company…
ID 405459542 · FY 2022–2024 · 3 years
კომპანიის ძირითადი საქმიანობის სფეროა საბითუმო ვაჭრობა ფარმაცევტული საქონლით 2.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Total Revenue | 9,551 | 8,906 | 6,448 | -17.8% |
| Total COGS | -8,059 | -8,009 | -4,565 | -24.7% |
| Gross Profit | 1,492 | 897 | 1,883 | +12.3% |
| Gross Margin | 15.6% | 10.1% | 29.2% | |
| Total Operating Expenses | -461 | -730 | -124 | -48.1% |
| EBITDA | 1,032 | 167 | 1,758 | +30.6% |
| EBITDA Margin | 10.8% | 1.9% | 27.3% | |
| Total D&A | -19 | -19 | -19 | +0.0% |
| EBIT / Operating Income | 1,013 | 148 | 1,740 | +31.1% |
| Total Interest Expense | 0 | 0 | -59 | |
| Total Other Income | 122 | 181 | 0 | +47.7% |
| Profit Before Tax | 1,135 | 329 | 1,680 | +21.7% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 1,135 | 329 | 1,680 | +21.7% |
| Net Margin | 11.9% | 3.7% | 26.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).